21
July
2009
|
00:00
Europe/Amsterdam

CB RICHARD ELLIS SELECTED BY PFIZER TO PROVIDE FACILITIES MANAGEMENT SERVICES FOR 10 EU OFFICES

London, 21 July 2009 – CB Richard Ellis Group, Inc (NYSE: CBG) has been selected by Pfizer Incorporated (NYSE: PFE), the world's largest research-based biomedical and pharmaceutical company, to provide facilities management services across 10 of Pfizer’s offices in nine European cities.

The initiative is aimed at establishing world class operating practices throughout Pfizer’s real estate portfolio through direct integration with CBRE’s European facility management infrastructure.

Matthew Pullen, Head of CBRE Global Corporate Services EMEA, said: “Pfizer are globally renowned as a leader in their industry and widely acknowledged for their commitment to innovation. CBRE’s engagement with Pfizer reflects this innovation and represents another important step in the evolution our European facilities management business. We continue to see strong demand from the world’s largest occupiers to leverage our outsourcing platform in order to drive down costs and streamline operating processes.”

CBRE were selected by Pfizer following a structured market evaluation process conducted over the last nine months.

ENDS

CONTACT:
Kieron Smith
+44 207 269 9363
kieron.smith@fd.com

About CB Richard Ellis
CB Richard Ellis Group, Inc. (NYSE:CBG), a Fortune 500 and S&P 500 company headquartered in Los Angeles, is the world’s largest commercial real estate services firm (in terms of 2008 revenue). The Company has approximately 30,000 employees (excluding affiliates), and serves real estate owners, investors and occupiers through more than 300 offices (excluding affiliates) worldwide. CB Richard Ellis offers strategic advice and execution for property sales and leasing; corporate services; property, facilities and project management; mortgage banking; appraisal and valuation; development services; investment management; and research and consulting. CB Richard Ellis has been named a BusinessWeek 50 “best in class” company three years in a row and a Fortune 100 fastest growing company two years in a row. Please visit our website at www.cbre.com.


About Pfizer Inc.
Pfizer is the world's largest research-based biomedical and pharmaceutical company and is headquartered in New York, with major research and development locations in the United States and England. They committed to being a global leader in health care and to helping change millions of lives for the better through providing access to safe, effective and affordable medicines and related health care services to the people who need them. They employ over 80,000 colleagues in 150 countries and invested $7.9 billion in research and development in 2008.